{"DataElement":{"publicId":"2749918","version":"1","preferredName":"Antiphospholipid Syndrome Involvement Type","preferredDefinition":"A syndrome associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses, marked by the presence of antibodies directed against phospholipids._To have a connection by participation or association or use; sharing in an activity or process._Something distinguishable as an identifiable class based on common qualities.","longName":"ANT_SYN_INV_TYP","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2749912","version":"1","preferredName":"Antiphospholipid Syndrome Involvement","preferredDefinition":"A syndrome associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses, marked by the presence of antibodies directed against phospholipids._To have a connection by participation or association or use; sharing in an activity or process.","longName":"ANT_SYN_INV","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2675009","version":"1","preferredName":"Antiphospholipid Syndrome","preferredDefinition":"A syndrome associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses, marked by the  presence of antibodies directed against phospholipids.","longName":"C61283","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antiphospholipid Syndrome","conceptCode":"C61283","definition":"A disorder caused by the presence of autoantibodies directed against phospholipids, causing a hypercoaguable state, which may result in blood clots, stroke, heart attack, and in women, significant pregnancy-related complications, including miscarriage and still birth. The syndrome is often associated with other autoimmune disorders, most commonly lupus erythematosus, and infections, including syphilis and Lyme disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"38B33F67-55F0-3ECE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-27","modifiedBy":"SBREXT","dateModified":"2008-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2192548","version":"1","preferredName":"Involvement","preferredDefinition":"To have a connection by participation or association or use; sharing in an activity or process.","longName":"C25548","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9F4C3B9-9218-0989-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-11-29","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D4AF823-AF7F-5557-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-15","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2749914","version":"1","preferredName":"Antiphospholipid Syndrome Involvement Type","preferredDefinition":"A syndrome associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses, marked by the presence of antibodies directed against phospholipids._To have a connection by participation or association or use; sharing in an activity or process._Something distinguishable as an identifiable class based on common qualities.","longName":"ANT_SYN_INV_TYP","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Thrombosis","valueDescription":"Thrombosis","ValueMeaning":{"publicId":"2684342","version":"1","preferredName":"Thrombosis","longName":"2684342","preferredDefinition":"(throm-BOW-sis) The formation or presence of a blood clot inside a blood vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombosis","conceptCode":"C26891","definition":"The formation of a blood clot in the lumen of a vessel or heart chamber; causes include coagulation disorders and vascular endothelial injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AE3EE33-A0BA-31C3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D4AF823-AFC5-5557-E044-0003BA3F9857","beginDate":"2008-05-15","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"CZECHS","dateModified":"2008-05-15","deletedIndicator":"No"},{"value":"CNS","valueDescription":"Central Nervous System","ValueMeaning":{"publicId":"2568673","version":"1","preferredName":"Central Nervous System","longName":"2568673","preferredDefinition":"The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D94E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-16","modifiedBy":"CZECHS","dateModified":"2008-06-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D4AF823-AFD2-5557-E044-0003BA3F9857","beginDate":"2008-05-15","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"CZECHS","dateModified":"2008-05-15","deletedIndicator":"No"},{"value":"Abortion","valueDescription":"Abortion","ValueMeaning":{"publicId":"2749915","version":"1","preferredName":"Abortion","longName":"2749915","preferredDefinition":"Any termination of pregnancy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abortion Finding","conceptCode":"C35221","definition":"The unintentional or intentional loss of a pregnancy before 22 weeks gestation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D4AF823-AFE0-5557-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D4AF823-AFF9-5557-E044-0003BA3F9857","beginDate":"2008-05-15","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"CZECHS","dateModified":"2008-05-15","deletedIndicator":"No"},{"value":"Hematological","valueDescription":"Hematology","ValueMeaning":{"publicId":"2749916","version":"1","preferredName":"Hematology","longName":"2749916","preferredDefinition":"Hematology; the branch of medicine that deals with the blood and blood-forming organs and the diseases thereof.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematology","conceptCode":"C16673","definition":"The branch of medicine that deals with the blood and blood-forming organs and the diseases thereof.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D4AF823-B01B-5557-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D4AF823-B034-5557-E044-0003BA3F9857","beginDate":"2008-05-15","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"CZECHS","dateModified":"2008-05-15","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2567790","version":"1","preferredName":"Other","longName":"2567790","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D5DB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4D4AF823-B040-5557-E044-0003BA3F9857","beginDate":"2008-05-15","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"CZECHS","dateModified":"2008-05-15","deletedIndicator":"No"},{"value":"Skin (livedo, vasculitis)","valueDescription":"Vasculitis","ValueMeaning":{"publicId":"2569497","version":"1","preferredName":"Vasculitis","longName":"2569497","preferredDefinition":"Inflammation of a blood vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vasculitis","conceptCode":"C26912","definition":"An inflammatory process involving the wall of the vessels (large, medium, or small-sized vessels). The inflammatory process may cause necrosis or formation of granulomas in the vascular wall. It may be the result of an autoimmune disorder, infection, or malignancy. Representative examples include polyarteritis nodosa, temporal arteritis, Wegener granulomatosis, Kawasaki disease, Takayasu arteritis, and Henoch-Schonlein purpura.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DC86-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-10","modifiedBy":"CZECHS","dateModified":"2008-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"50AB51CD-996D-4D05-E044-0003BA3F9857","beginDate":"2008-05-15","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-06-27","modifiedBy":"NYCHM","dateModified":"2008-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2749913","version":"1","preferredName":"Antiphospholipid Syndrome Involvement Type","preferredDefinition":"A syndrome associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses, marked by the  presence of antibodies directed against phospholipids.:To have a connection by participation or association or use; sharing in an activity or process.:Type; a subdivision of a particular kind of thing.","longName":"C61283:C25548:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antiphospholipid Syndrome","conceptCode":"C61283","definition":"A disorder caused by the presence of autoantibodies directed against phospholipids, causing a hypercoaguable state, which may result in blood clots, stroke, heart attack, and in women, significant pregnancy-related complications, including miscarriage and still birth. The syndrome is often associated with other autoimmune disorders, most commonly lupus erythematosus, and infections, including syphilis and Lyme disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D4AF823-AF9F-5557-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-15","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"ONEDATA","dateModified":"2008-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D4AF823-AFB0-5557-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-15","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PerformedDiagnosis:resultClassificationCode ","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"For the antiphospholipid synd","type":"Preferred Question Text","description":"For the antiphospholipid syndrome, what was the involved organ or clinical problem?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2749918","type":"BRIDG Mapping Path","description":"PerformedDiagnosis.resultClassificationCode WHERE PerformedDiagnosis.value = \"antiphospholipid syndrome\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D4C2199-329F-5FCF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-15","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"ALEYR","dateModified":"2019-04-07","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}